Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.42 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3791776 | 1.00 | CETP (0.43) | CETPFAAHMEN1MAPK1KMT2A | |
| SCHEMBL3777691 | 1.00 | CETP (0.43) | CETPFAAHMEN1MAPK1KMT2A | |
| SCHEMBL3779701 | 0.98 | RAB9A (0.41) | CETPFAAHMEN1MAPK1KMT2A | |
| SCHEMBL3782883 | 0.90 | HAO1 (0.40) | GAALMNA | |
| SCHEMBL3788057 | 0.90 | HAO1 (0.40) | GAALMNA | |
| SCHEMBL3784637 | 0.89 | MAPT (0.39) | MEN1KMT2A | |
| SCHEMBL13124981 | 0.78 | MAPT (0.33) | CETPMEN1MAPK1KMT2AGAA | |
| SCHEMBL13124975 | 0.78 | MAPT (0.33) | CETPMEN1MAPK1KMT2AGAA | |
| SCHEMBL16118213 | 0.72 | LMNA (0.61) | FAAHLMNAHSP90AA1SOAT1POLB | |
| SCHEMBL13370098 | 0.71 | RAB9A (0.43) | CETPMEN1MAPK1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436210-B2 | Amide compound and bacterial disease control agent for agricultural and horticultural use | THE UNIVERSITY OF TOKYO (JP) | 2013-05-07 | — | — | US | disclosed |
| US-8436210-B2 | Amide compound and bacterial disease control agent for agricultural and horticultural use | THE UNIVERSITY OF TOKYO (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20100261920-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | THE UNIVERSITY OF TOKYO (JP) | 2010-10-14 | — | — | US | disclosed |
| US-20100261920-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | THE UNIVERSITY OF TOKYO (JP) | 2010-10-14 | — | — | US | disclosed |
| US-20100261920-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | THE UNIVERSITY OF TOKYO (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2221293-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | The University of Tokyo (JP) | 2010-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261920-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | BROX, NAAA, H1-2 | CETP 2321/4885FAAH 92/4885MEN1 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.